DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia

Leukemia Research

Volumn 34, Issue 10, 2010, Pages 1275-1281

  Tumer, Tugba Boyunegmez ^a,b   Yilmaz, Duygu ^a   Tanrikut, Cihan ^a   Sahin, Gurses ^c   Ulusoy, Gulen ^a,d   Arinç, Emel ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^d KOÇ UNIVERSITY   (Turkey)

Author keywords

Childhood ALL; CYP2E1; Genetic polymorphism; Risk assessment; XRCC1

Indexed keywords

CYTOCHROME P450 2E1; GENOMIC DNA; XRCC1 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RISK; CHILD; CODON; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE; TURKEY (REPUBLIC);

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP2E1; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; INFANT; MALE; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK;

EID: 77955984748     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.02.035     Document Type: Article

References (49)

1. Linet M.S., Ries L.A., Smith M.A., Tarone R.E., Devesa S.S. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999, 91:1051-1058.
2. Ross J.A., Davies S.M., Potter J.D., Robison L.L. Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev 1994, 16:243-272.
3. McKinney P.A., Alexander F.E., Cartwright R.A., Parker L. Parental occupations of children with leukaemia in west Cumbria, north Humberside, and Gateshead. BMJ 1991, 302:681-687.
4. Parental occupation at periconception: findings from the United Kingdom Childhood Cancer Study. Occup Environ Med 2003, 60:901-909. UK Childhood Cancer Study Investigators.
5. Arinç E., Sen A. Effects of in vivo benzo (a)pyrene treatment on liver microsomal mixed-function oxidase activities of gilthead seabream (Sparus aurata). Comp Biochem Physiol Pharmacol Toxicol Endocrinol 1994, 107(3):405-414.
6. Johansson I., Ingelman-Sundberg M. Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 1988, 48:5387-5390.
7. Arinç E., Adali O., Gencler-Ozkan A.M. Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 2000, 74:329-334.
8. Arinç E., Arslan S., Adali O. Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver. Arch Toxicol 2005, 79:427-433.
9. Arinç E., Arslan S., Bozcaarmutlu A., Adali O. Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol 2007, 45:107-118.
10. Shen M.R., Jones L.M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998, 58:604-608.
11. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000, 92:874-897.
12. Caldecott K.W., Aoufouchi S., Johnson P., Shall S. XRCC1 polypeptide interacts with DNA polymerase β and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res 1996, 24:4387-4394.
13. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly (ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 1998, 18:3563-3571.
14. Whitehouse C.J., Taylor R.M., Thistlethwaite A., Zhang H., Karimi-Busheri F., Lasko D.D., et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001, 104:107-117.
15. Vidal A.E., Boiteux S., Hickson I.D., Radicella J.P. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001, 20:6530-6539.
16. Lindahl T., Wood R.D. Quality control by DNA repair. Science 1999, 286:1897-1905.
17. Sak S.C., Barrett J.H., Paul A.B., Bishop D.T., Kiltie A.E. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet 2007, 8:13.
18. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999, 59(11):2557-2561.
19. Zhang X., Moréra S., Bates P.A., Whitehead P.C., Coffer A.I., Hainbucher K., et al. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J 1998, 17(21):6404-6411.
20. Abdel-Rahman S.Z., El-Zein R.A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 2000, 159(1):63-71.
21. Park J.Y., Lee S.Y., Jeon H.S., Bae N.C., Chae S.C., Joo S., et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002, 1:23-27.
22. Chacko P., Rajan B., Joseph T., Mathew B.S., Pillai M.R. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 2005, 89(1):15-21.
23. Xu Z., Qian L.X., Hua L.X., Wang X.R., Yang J., Zhang W., et al. Relationship between DNA repair gene XRCC1 Arg399Gln polymorphism and susceptibility to prostate cancer in the Han population in Jiangsu and Anhui. Zhonghua Nan Ke Xue 2007, 13(4):327-331.
24. Wang Y., Spitz M.R., Zhu Y., Dong Q., Shete S., Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003, 2:901-908.
25. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005, 162(10):925-942.
26. Sturgis E.M., Castillo E.J., Li L., Zheng R., Eicher S.A., Clayman G.L., et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999, 20:2125-2129.
27. Shen H., Xu Y., Qian Y., Yu R., Qin Y., Zhou L., et al. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 2000, 88:601-606.
28. Stern M.C., Umbach D.M., van-Gils C.H., Lunn R.M., Taylor J.A. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10:125-131.
29. Joseph T., Kusumakumary P., Chacko P., Abraham A., Pillai M.R. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 2005, 217(1):17-24.
30. Pakakasama S., Sirirat T., Kanchanachumpol S., Udomsubpayakul U., Mahasirimongkol S., Kitpoka P., et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007, 48(1):16-20.
31. Batar B., Güven M., Bariş S., Celkan T., Yildiz I. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2009, 33(6):759-763.
32. Ulusoy G., Adali O., Tumer T.B., Sahin G., Gozdasoglu S., Arinç E. Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia. Oncology 2007, 72(1-2):125-131.
33. Tumer T.B., Ulusoy G., Adali O., Sahin G., Gozdasoglu S., Arinç E. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia. Am J Hematol 2007, 82(10):906-910.
34. Lahiri D., Schnabel B. DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 1993, 31:321-328.
35. Xing D., Qi J., Miao X., Lu W., Tan W., Lin D. Polymorphisms of DNA repair Genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 2002, 100(5):600-605.
36. Krajinovic M., Labuda D., Richer C., Karimi S., Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999, 93(5):1496-1501.
37. Rollinson S., Roddam P., Kane E., Roman E., Cartwright R., Jack A., et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis 2000, 1:43-47.
38. Joseph T., Kusumakumary P., Chacko P., Abraham A. Radhakrishna Pillai M. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer 2004, 43(5):560-567.
39. Ross D. Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity. Chem Biol Interact 2005, 153-154:137-146.
40. Parke D.V. Activation mechanisms to chemical toxicity. Arch Toxicol 1987, 60:5-15.
41. Parke D.V. The cytochromes P450 and mechanisms of chemical carcinogenesis. Environ Health Perspect 1994, 102:852-853.
42. Ioannides C., Lewis D.F.V., Parke D.V. Mechanisms of chemical carcinogenesis and molecular parametric analyis in the safety evaluation of chemicals. Drugs, Diet and Disease 1995, vol. 1:147-160. Ellis Horwood Publishers, Chichester.
43. Hoeijmakers J.H.J. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
44. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001, 12:1239-1248.
45. Ulusoy G., Arinç E., Adali O. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol 2007, 10:711-718.
46. Vural P., Deĝirmencioĝlu S., Doĝru-Abbasoĝlu S., Saral N.Y., Akgül C., Uysal M. Genetic polymorphisms in DNA repair gene APE1, XRCC1 and XPD and the risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2009, 146(2):160-164.
47. Harth V., Schafer M., Abel J., Maintz L., Neuhaus T., Besuden M., et al. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A 2008, 71(13-14):887-897.
48. Coppede F., Migheli F., Lo Gerfo A., Fabbrizi M.R., Carlesi C., Mancuso M., et al. Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009, 25:1-3.
49. Lee S.G., Kim B., Choi J., Kim C., Lee I., Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett 2002, 187:53-60.